Australia markets closed

BioSyent Inc. (RX.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
10.37+0.16 (+1.57%)
At close: 03:59PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
7,054
6,460
5,458
6,282
3,795
-
Depreciation & amortisation
459.91
455.338
450.998
457.106
510.422
-
Deferred income taxes
-314.034
-133.969
-8.844
-68.246
-27.616
-
Stock-based compensation
518.99
513.486
439.671
334.41
266.173
-
Change in working capital
336.812
-1,451
-1,093
-2,175
2,494
-
Inventory
-1,133
-1,482
-2,437
-130.77
65.566
-
Accounts payable
13.723
14.794
1,500
-160.352
942.592
-
Other working capital
7,020
4,881
4,429
4,582
6,720
-
Other non-cash items
-1,203
-1,079
-454.876
-76.193
-215.82
-
Net cash provided by operating activities
7,109
5,055
4,949
4,675
6,894
-
Cash flows from investing activities
Investments in property, plant and equipment
-88.871
-174.23
-519.317
-93.181
-174.298
-
Purchases of investments
-939.328
-2,500
-10,655
-4,890
-
-939.328
Sales/maturities of investments
3,207
2,629
-
-
-
-
Other investing activities
-11.538
158.766
192.759
-
-
-11.538
Net cash used for investing activities
218.676
883.847
-10,790
-4,837
3,388
-
Cash flows from financing activities
Debt repayment
-176.171
-174.055
-161.812
-151.949
-144.253
-
Common stock repurchased
-4,165
-3,253
-3,689
-1,849
-3,142
-
Dividends paid
-1,953
-1,913
-483.958
0
0
-
Other financing activities
-324.701
-443.472
-
-
-
-
Net cash used provided by (used for) financing activities
-6,618
-5,785
-4,371
-2,076
-3,372
-
Net change in cash
644.919
119.975
-10,171
-2,256
6,850
-
Cash at beginning of period
6,418
7,865
18,035
20,291
13,442
-
Cash at end of period
7,128
7,985
7,865
18,035
20,291
-
Free cash flow
Operating cash flow
7,109
5,055
4,949
4,675
6,894
-
Capital expenditure
-88.871
-174.23
-519.317
-93.181
-174.298
-
Free cash flow
7,020
4,881
4,429
4,582
6,720
-